Skip to main content

Table 2 Clinicopathological and genetic characteristics of the 17 cases with biologically relevant or actionable variants

From: Genetic characterisation of molecular targets in carcinoma of unknown primary

Sample ID

Anatomical location

Morphology

Gender

Age

% of tumour cellularity

Sampling method

Gene

Amino acid change

Copy number detected

Allele ratio

Detected by both Panels

Actionable target

1

Lymph node (cervical)

SCC

F

62

80

TS

TP53

G245D

 

0.79

  
      

CCND1

 

12.31

  

Yes

      

FGFR1

 

8.31

  

Yes

      

MYC

 

10

  

Yes

2

Lymph node (inguinal)

SCC

M

67

90

TS

TP53

I195N

 

0.13

  

3

Lymph node (inguinal)

SCC

F

51

100

Macro

CDKN2A

D74N

 

0.35

  
      

PIK3CA

E545K

 

0.17

Yes

Yes

4

Lymph node (mesenteric)

PD Carcinoma

F

81

100

LCM

BRAF

V600E

 

0.22

Yes

Yes

5

Maxillary sinus

SCC

F

79

90

TS

TP53

R248W

 

0.23

  
       

TP53

P177L

 

0.29

  
       

ERBB2

S310F

 

0.28

 

Yes

6

Parotid

SCC

M

54

100

Macro

TP53

E286K

 

0.08

  

7

Skin

Neuroendocrine Ca

F

81

95

TS

MET

R988C

 

0.4

 

Yes

8

Submandibular gland

SCC

M

81

95

TS

MYC

 

6.97

  

Yes

9

Bone

PD Carcinoma

F

80

50

TS

MET

T1010I

 

0.49

Yes

Yes

10

Bone

Adenocarcinoma

M

71

100

LCM

KRAS

G12D

 

0.67

Yes

Yes

11

Lymph node (axillary)

Adenocarcinoma

F

82

80

TS

TP53

Q165Ter

 

0.51

  

12

Omentum

Adenocarcinoma

F

68

100

LCM

TP53

R175H

 

0.75

  

13

Parotid

SCC

M

79

100

Macro

TP53

S241F

 

0.28

  
      

TP53

P152L

 

0.22

  

14

Parotid

PD Carcinoma

F

76

100

Macro

HRAS

G13N

 

0.51

Yes

Yes

      

HRAS

G13S

 

0.51

Yes

Yes

15

Thyroid

SCC

F

80

100

Macro

MLH1

V384D

 

0.5

  
      

BRAF

V600E

 

0.12

Yes

Yes

16

Brain

PD Carcinoma

M

74

80

TS

KRAS

G12A

 

0.61

Yes

Yes

17

Liver

PD Carcinoma

F

66

80

TS

TP53

R175H

 

0.57

  
  1. Characteristics of the CUP cases includes the sample ID, anatomical location where the CUP originated from, the histopathological morphology of the specimen, the gene the variant was detected in, the protein change, total number of gene copies detected, the allele ratio of single nucleotide variants (SNVs), and whether the variant identified was actionable
  2. SCC squamous cell carcinoma, F female, M male, PD poorly differentiated, Ca carcinoma, TS tissue sections, macro macrodissection, LCM laser capture microdissection